The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

DMPX     3,7-dimethyl-1-prop-2-ynyl- purine-2,6-dione

Synonyms: Lopac-D-134, CHEMBL282038, D134_SIGMA, AG-L-63646, ANW-57638, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of DMPX

 

Psychiatry related information on DMPX

 

High impact information on DMPX

 

Biological context of DMPX

 

Anatomical context of DMPX

 

Associations of DMPX with other chemical compounds

 

Gene context of DMPX

  • In contrast, the selective A1AR agonist, chloro-N6-cyclopentyladenosine (CCPA) and the A2AR antagonist, 3,7-dimethyl-1-propargylxanthine (DMPX) enhanced each stimulant-induced TF activity expression [19].
  • However, in oxidized cells, when DPCPX was tested together with CPA 100 nM the total release of D-[3H]aspartate increased from 5.1 +/- 0.4% to 11.4 +/- 1.0%, this increase being reverted by 3,7-dimethyl-1-propargylxanthine (DMPX; 100 nM), an antagonist of A2A adenosine receptors [20].
  • The action of CGS-21680 was mediated via the A2 receptors since its effect on TNF production was blocked by 3,7-dimethyl-1-propargylxanthine (DMPX) but not by xanthine amine cogener (XAC), antagonists selective for the A2 and A1 receptors, respectively [21].

References

  1. Effects of adenosine receptor subtypes on hippocampal extracellular serotonin level and serotonin reuptake activity. Okada, M., Kawata, Y., Kiryu, K., Mizuno, K., Wada, K., Tasaki, H., Kaneko, S. J. Neurochem. (1997) [Pubmed]
  2. Hypoglycemia selectively abolishes hypoxic reactivity of pial arterioles in piglets: role of adenosine. Park, T.S., Gonzales, E.R., Shah, A.R., Gidday, J.M. Am. J. Physiol. (1995) [Pubmed]
  3. The intrastratial injection of an adenosine A(2) receptor antagonist prevents frontal cortex EEG abnormalities in a rat model of Huntington's disease. Reggio, R., Pèzzola, A., Popoli, P. Brain Res. (1999) [Pubmed]
  4. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. Cronstein, B.N., Naime, D., Ostad, E. J. Clin. Invest. (1993) [Pubmed]
  5. Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Merrill, J.T., Shen, C., Schreibman, D., Coffey, D., Zakharenko, O., Fisher, R., Lahita, R.G., Salmon, J., Cronstein, B.N. Arthritis Rheum. (1997) [Pubmed]
  6. In vivo effects of adenosine A(2) receptor agonist and antagonist on neuronal and astrocytic intermediary metabolism studied with ex vivo (13)C MR spectroscopy. Hammer, J., Qu, H., Håberg, A., Sonnewald, U. J. Neurochem. (2001) [Pubmed]
  7. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists. Müller, C.E., Geis, U., Hipp, J., Schobert, U., Frobenius, W., Pawłowski, M., Suzuki, F., Sandoval-Ramírez, J. J. Med. Chem. (1997) [Pubmed]
  8. Mechanism of vasodilation to adenosine in coronary arterioles from patients with heart disease. Sato, A., Terata, K., Miura, H., Toyama, K., Loberiza, F.R., Hatoum, O.A., Saito, T., Sakuma, I., Gutterman, D.D. Am. J. Physiol. Heart Circ. Physiol. (2005) [Pubmed]
  9. Differential effects of diadenosine phosphates on purinoceptors in the rat isolated perfused kidney. van der Giet, M., Khattab, M., Börgel, J., Schlüter, H., Zidek, W. Br. J. Pharmacol. (1997) [Pubmed]
  10. A role for adenosine A2 receptors in the induction of long-term potentiation in the CA1 region of rat hippocampus. Kessey, K., Trommer, B.L., Overstreet, L.S., Ji, T., Mogul, D.J. Brain Res. (1997) [Pubmed]
  11. Effects of CGS 21680 in vivo on dopamine D2 agonist binding in the rat brain. Hillefors-Berglund, M., Hedlund, P.B., von Euler, G. Brain Res. (1995) [Pubmed]
  12. Modulation of vasopressin actions on human platelets by plasma adenosine and theophylline: gender differences. Agarwal, K.C. J. Cardiovasc. Pharmacol. (1993) [Pubmed]
  13. Roles of adenosine receptors in the regulation of kainic acid-induced neurotoxic responses in mice. Lee, H.K., Choi, S.S., Han, K.J., Han, E.J., Suh, H.W. Brain Res. Mol. Brain Res. (2004) [Pubmed]
  14. The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites. Gadangi, P., Longaker, M., Naime, D., Levin, R.I., Recht, P.A., Montesinos, M.C., Buckley, M.T., Carlin, G., Cronstein, B.N. J. Immunol. (1996) [Pubmed]
  15. Vasodilatation produced by adenosine in isolated rat perfused mesenteric artery: a role for endothelium. Tabrizchi, R., Lupichuk, S.M. Naunyn Schmiedebergs Arch. Pharmacol. (1995) [Pubmed]
  16. Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Hashimoto, E., Kage, K., Ogita, T., Nakaoka, T., Matsuoka, R., Kira, Y. Biochem. Biophys. Res. Commun. (1994) [Pubmed]
  17. The effect of anoxia on cardiomyocyte glucose transport does not involve an adenosine release or a change in energy state. Eblenkamp, M., Böttcher, U., Thomas, J., Löken, C., Ionescu, I., Rose, H., Kammermeier, H., Fischer, Y. Life Sci. (1996) [Pubmed]
  18. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. Alfinito, P.D., Wang, S.P., Manzino, L., Rijhsinghani, S., Zeevalk, G.D., Sonsalla, P.K. J. Neurosci. (2003) [Pubmed]
  19. Adenosine regulates tissue factor expression on endothelial cells. Deguchi, H., Takeya, H., Urano, H., Gabazza, E.C., Zhou, H., Suzuki, K. Thromb. Res. (1998) [Pubmed]
  20. Adenosine modulation of D-[3H]aspartate release in cultured retina cells exposed to oxidative stress. Agostinho, P., Caseiro, P., Rego, A.C., Duarte, E.P., Cunha, R.A., Oliveira, C.R. Neurochem. Int. (2000) [Pubmed]
  21. Inhibition of LPS-induced TNF alpha production in human monocytes by adenosine (A2) receptor selective agonists. Prabhakar, U., Brooks, D.P., Lipshlitz, D., Esser, K.M. Int. J. Immunopharmacol. (1995) [Pubmed]
 
WikiGenes - Universities